Hybrid closed-loop systems are increasingly gaining recognition as a gold-standard option for diabetes management, and medtech makers are jumping at the opportunity to add their own artificial ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, Dexcom, Inc.

The National Institute for Health and Care Excellence (NICE), England’s cost-effectiveness watchdog, has finalized a draft guidance regarding hybrid closed-loop systems, concluding that the technology ...

A new clinical trial to investigate the use of artificial pancreas system is set to begin, bringing in touchscreen insulin pump maker Tandem Diabetes Care; Dexcom, which makes continuous glucose ...

With hybrid closed-loop systems for automated insulin delivery increasingly being seen as life changing for people with diabetes, Vicentra BV has teamed up with Diabeloop SA and Dexcom Inc. to launch ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Data were derived from Ebekozien O, et al. OP 020.

HAMBURG, Germany -- A hybrid closed-loop insulin therapy system significantly improved glycemic control among pregnant women with type 1 diabetes, the randomized AiDAPT trial showed. Meeting the ...

The algorithm allows users to manage their type 1 diabetes without needing to count carbohydrates or providing pre-meal ...